TY - JOUR
T1 - Binding of a Staphylococcus aureus bone pathogen to type I collagen
AU - Buxton, Thomas B.
AU - Rissing, John Peter
AU - Horner, Jack A.
AU - Plowman, Kent
AU - Scott, David F.
AU - Sprinkle, Terry J.
AU - Best, Gary K.
PY - 1990/6
Y1 - 1990/6
N2 - We contrasted the collagen-binding potential of the experimental osteomyelitis pathogen, Staphylococcus aureus strain SMH, to several other strains. These included Cowan 1 (binder), Wood 46 (non-binder) and six capsular variants. These measurements were made using an 125I-collagen binding assay. Formalin-killed S. aureus SMH strongly bound commercial type I iodinated collagen (dissociation contant, Kd = 2 × 10-9 m). The extent of binding was similar to Cowan 1. Binding was saturable and not inhibited by 100 mm solutions of d-glucose, d-galactose, d-mannose, methyl-α-l-fucopyranoside, l-hydroxyproline or l-glycine. d-lactose gave moderate inhibition of binding to collagen, and l-fucose was strongly inhibitory. Trypsinized SMH did not bind collagen. None of four Ruthenium-red-staining staphylococci (encapsulated) avidly bound type I collagen. The encapsulated Smith strain, for example, did not bind to collagen but its capsule-negative variant, Smith compact, showed extensive binding. Three of five non-encapsulated S. aureus were strong collagen binders. These data suggest that the prototype bone pathogen binds to the major protein component of bone's extracellular matrix. Collagen-binding is promoted by protein adhesin(s), not capsule. The latter, in fact, appeared to interfere with this interaction. Binding was inhibited by solutions containing the simple monosaccharide, l-fucose.
AB - We contrasted the collagen-binding potential of the experimental osteomyelitis pathogen, Staphylococcus aureus strain SMH, to several other strains. These included Cowan 1 (binder), Wood 46 (non-binder) and six capsular variants. These measurements were made using an 125I-collagen binding assay. Formalin-killed S. aureus SMH strongly bound commercial type I iodinated collagen (dissociation contant, Kd = 2 × 10-9 m). The extent of binding was similar to Cowan 1. Binding was saturable and not inhibited by 100 mm solutions of d-glucose, d-galactose, d-mannose, methyl-α-l-fucopyranoside, l-hydroxyproline or l-glycine. d-lactose gave moderate inhibition of binding to collagen, and l-fucose was strongly inhibitory. Trypsinized SMH did not bind collagen. None of four Ruthenium-red-staining staphylococci (encapsulated) avidly bound type I collagen. The encapsulated Smith strain, for example, did not bind to collagen but its capsule-negative variant, Smith compact, showed extensive binding. Three of five non-encapsulated S. aureus were strong collagen binders. These data suggest that the prototype bone pathogen binds to the major protein component of bone's extracellular matrix. Collagen-binding is promoted by protein adhesin(s), not capsule. The latter, in fact, appeared to interfere with this interaction. Binding was inhibited by solutions containing the simple monosaccharide, l-fucose.
KW - Staphylococcus aureus
KW - collagen
KW - collagen-binding
KW - l-fucose
KW - osteomyelitis
UR - http://www.scopus.com/inward/record.url?scp=0025447791&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025447791&partnerID=8YFLogxK
U2 - 10.1016/0882-4010(90)90031-K
DO - 10.1016/0882-4010(90)90031-K
M3 - Article
C2 - 2266856
AN - SCOPUS:0025447791
SN - 0882-4010
VL - 8
SP - 441
EP - 448
JO - Microbial Pathogenesis
JF - Microbial Pathogenesis
IS - 6
ER -